Formulary Decisions
Search for the outcome of decisions made by the Formulary Committee
Etanercept
Enbrel
Not routinely available
NICE (TA383 (SMC 212/05))
01/07/2019
Indication
For the treatment of severe active ankylosing spondylitis.
Therapeutic Area
Musculoskeletal and joint diseases
Status Description
Not routinely available as local clinical experts do not wish to add the medicine to the formulary at this time or there is a local preference for alternative medicines
Formulation
25mg vial of powder for subcutaneous injection
Comments
January 2006 - Added to the LJF, for Specialist Use only. February 2016 - NICE MTA advice: SMC advice 212/05 is superseded by NICE TA383. July 2019 (as per LJF) - Not routinely available as local clinical experts do not wish to add the medicine to the formulary at this time or there is a local preference for alternative medicines.
Link to Advice
Advice Published
01/02/2016